I-Rabeprazole Hydroxy Compound CAS 675198-19-3 Purity >99.5% (HPLC) Isithombe Esifakiwe Sefekthri

I-Rabeprazole Hydroxy Compound CAS 675198-19-3 Purity >99.5% (HPLC) Factory

Incazelo emfushane:

Igama Lekhemikhali: [4-(3-Methyoxypropoxy)-3-Methyl-2-Pyridinyl]methanol Hydrochloride

Synonyms: Rabeprazole Hydroxy Compound

CAS: 675198-19-3

Ubumsulwa: >99.5% (HPLC)

Ukubukeka: I-Crystalline Powder Ephuzi Ekhanyayo

I-Intermediate ye-Rebeprazole Sodium CAS 117976-90-6

E-Mail: alvin@ruifuchem.com

Thumela i-imeyili kithi

Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Ruifu Chemical Supply Rabeprazole Sodium Intermediates
I-Rabeprazole Sodium CAS 117976-90-6
I-Rabeprazole Hydroxy Compound CAS 675198-19-3
I-Rabeprazole Chloride Compound CAS 153259-31-5

Chemical Properties:

Igama Lekhemikhali	[4-(3-Methyoxypropoxy)-3-Methyl-2-Pyridinyl]methanol Hydrochloride
Omqondofana	I-Rabeprazole Hydroxy Compound;(4-(3-Methoxypropoxy)-3-Methylpyridin-2-yl)methanol Hydrochloride;4-(3-Methoxypropoxy)-3-Methylpyridine-2-Methanol Hydrochloride
Inombolo ye-CAS	675198-19-3
Inombolo yeCAT	I-RF-PI1919
Isimo Sesitoko	Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani
I-Molecular Formula	I-C11H18ClNO3
Isisindo samangqamuzana	247.72
Ibhrendi	I-Ruifu Chemical

Imininingwane:

Into	Imininingwane
Ukubukeka	I-Crystalline Powder Ephuzi Ekhanyayo
Indlela Yokuhlola / Yokuhlaziya	>99.5% (HPLC)
Ukulahlekelwa Ekumisweni	<0.50%
Izinsalela ekushiseni	<0.20%
Noma Ikuphi Ukungcola Okukodwa	<0.50%
Ukungcola Okuphelele	<0.50%
Izinsimbi Ezisindayo	<20ppm
Izinga Lokuhlola	I-Enterprise Standard
Ukusetshenziswa	I-Intermediate ye-Rebeprazole Sodium (CAS: 117976-90-6)

I-Rabeprazole Hydroxy Compound CAS 675198-19-3 Umzila Wokwenziwa

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama

Izinzuzo:

I-FAQ:

Isicelo:

[4-(3-Methyoxypropoxy)-3-Methyl-2-Pyridinyl]methanol Hydrochloride, Rabeprazole Hydroxy Compound, (CAS: 675198-19-3) iphakathi kwe-Rebeprazole Sodium (CAS: 117976-90-6).I-Rabeprazole sodium azole canker iyisigaba se-proton pump inhibitor ethatha izidakamizwa, ifomu le-ray Bella azole sodium kasawoti, okokuqala yinkampani yaseJapane i-Eisai eyathuthukiswa ngempumelelo okokuqala ngqa, igama lempahla yamandla wamaza, indima ye-proton pump inhibitors ukunciphisa ukukhishwa kwe-gastric acid yezindawo zezifo ezizinzile, ukuze welaphe izilonda zesisu kanye ne-duodenal kanye nomphumela wesifo se-esophagus regurgitation.Isetshenziswa kakhulu ekwelapheni izifo ezihlobene ne-asidi, njengokukhethwa kwezilonda zesisu kanye ne-duodenal, isilonda se-peptic, isifo se-reflux ye-gastroesophageal, i-zhuoye syndrome njalonjalo.I-Rebeprazole sodium iqala ukusebenza ngokushesha uma iqhathaniswa ne-omeprazole, kodwa isikhathi sokusebenza sifushane.I-Rabeprazole ithatha indawo ye-benzimidazole evimbela ukukhishwa kwe-asidi esiswini ngokubopha iphampu ye-proton yamaseli e-gastric parietal.Lo mkhiqizo uvimbela isenzo se-adenosine triphosphate, i-enzyme eyinhloko ekukhiqizeni i-gastric acid.Ingavimbela ukukhishwa kwe-asidi eyisisekelo yesisu kanye ne-gastric acid ebangelwa ukugqugquzela.